Somatostatin5 receptor-mediated [35S]guanosine-5'-O-(3- thio)triphosphate binding: Agonist potencies and the influence of sodium chloride on intrinsic activity

Molecular Pharmacology

Volumn 51, Issue 6, 1997, Pages 1060-1069

  Williams, Andrea J ^a,b   Michel, Anton D ^a   Feniuk, Wasyl ^a   Humphrey, Patrick P A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYL DEXTRO [3 (2 NAPHTHYL)ALANINAMIDE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; L 362855; LIGAND; PERTUSSIS TOXIN; RADIOLIGAND; SODIUM; SODIUM CHLORIDE; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN RECEPTOR; SULFUR 35; CYCLOPEPTIDE; DRUG DERIVATIVE; OLIGOPEPTIDE; RECOMBINANT PROTEIN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 5; SULFUR;

AGONIST; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG POTENCY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; KINETICS; METABOLISM; STIMULATION; ULTRASTRUCTURE;

ANIMALS; BINDING SITES; CHO CELLS; CRICETINAE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KINETICS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; RECEPTORS, SOMATOSTATIN; RECOMBINANT PROTEINS; SODIUM CHLORIDE; SOMATOSTATIN; STIMULATION, CHEMICAL; SULFUR RADIOISOTOPES; TRANSFECTION;

EID: 0030610397     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.6.1060     Document Type: Article

References (40)

1. Epelbaum, J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog. Neurobiol. 27:63-100 (1986).
2. Mandarino, I., D. Stenner, W. Blanchard, S. Nissen, J. Gerich, N. Ling, P. Brazeau, P. Bohlen, F. Esch, and R. Guillemen. Selective effects of somatostatin-14, -25, and -28 on in vitro insulin and glucagon secretion. Nature (Lond.) 291:76-77 (1981).
3. Bloom, S., C. Mortimer, M. Thorner, G. Besser, R. Hall, A. Gomez-Pan, U. Roy, R. Russel, D. Coy, A. Kastin, and A. Schally. Inhibition of gastrin and gastric acid secretion by growth hormone release-inhibiting hormone. Lancet 2:1106-1109 (1974).
4. Yamada, Y., S. Post, K. Wang, H. Tager, G Bell, and S. Seino. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA 89:251-255 (1992).
5. Vanetti, M., M. Kouba, X. Wang, G, Vogt, and V. Hollt. Cloning and expression of a novel mouse somatostatin receptor. FEBS. Lett 311:290-294 (1992).
6. Yasuda, K., S. Rens-Domiano, C. Breder, S. Law, C. Saper, T. Reisine, and G. Bell. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylyl cyclase. J. Biol. Chem. 267:20422-20428 (1992).
7. Bruno, J., Y. Xu, J. Song, and M. Berelowitz. Molecular cloning and functional expression of a novel brain specific somatostatin receptor. Proc. Natl. Acad. Sci. USA 89:11151-11155 (1992).
8. O'Carroll, A.-M., S. Lolait, M. Konig, and L. Mahan. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol. Pharmacol. 42:939-946 (1992).
9. Yamada, Y., S. Kagimoto, A. Kubota, K. Yasuda, K. Masuda, Y. Someya, Y. Ihara, Q. Li, H. Imura, S. Seino, and Y. Seino. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys. Res. Commun. 195:844-852 (1993).
10. Inoue, M., S. Nakajima, and Y. Nakajima. Somatostatin induces an inward rectification in rat locus coeruleus neurones through a pertussis toxin-sensitive mechanism. J. Physiol. 407:177-198 (1988).
11. Wang, H.-L., T. Reisine, M. Dichter. Somatostatin-14 and somatostatin-28 inhibit calcium currents in rat neocortical neurons. Neuroscience 38:335-342 (1990).
12. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS. Lett 348:192-196 (1994).
13. Liebow, C., C. Reilly, M. Serrano, and A. Schally. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 86:2003-2007 (1989).
14. Patel, Y. C., M. T. Greenwood, A. Warszynska, R. Panetta, and C. B. Srikant. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem. Biophys. Res. Commun. 198:605-612 (1994).
15. Raynor, K., A.-M. O'Carroll, H. Kong, K. Yasuda, L. C. Mahan, G. I. Bell, and T. Reisine. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol. Pharmacol. 44:385-392 (1993).
16. Panetta, R., M. T. Greenwood, A. Warszynska, L. L. Demchyshyn, R. Day, H. B. Niznik, C. B. Srikant, and Y. C. Patel. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol. Pharmacol. 45:417-427 (1994).
17. O'Carroll, A.-M., K. Raynor, S. Lolait, and T. Reisine. Characterization of cloned human somatostatin receptor SSTR5. Mol. Pharmacol. 46:291-298 (1994).
18. 5 receptor. Br. J. Pharmacol. 118:445-447 (1996).
19. 5 receptors expressed in CHO-K1 cells mediate increases in extracellular acidification by pertussis toxin-sensitive and -insensitive pathways. Br. J. Pharmacol. 117:9P (1996).
20. 5 receptor couples to pertussis toxin-sensitive and -insensitive G proteins. Br. J. Pharmacol. 119:11P (1996).
21. 35S]-GTPγS binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br. J. Pharmacol. 109:1120-1127 (1993).
22. Burford, N. T., A. B. Tobin, and S. R. Nahorski. Coupling of muscarinic ml, m2 and m3 acetylcholine receptors, expressed in Chinese hamster ovary cells, to pertussis toxin-sensitive/insensitive guanine nucleotide-binding proteins. Eur. J. Pharmacol. 289:343-351 (1995).
23. 35S]thio)t-riphosphate binding. Mol. Pharmacol. 44:115-123 (1993).
24. Jenkinson, D. H., E. A. Barnard, D. Hoyer, P. P. A. Humphrey, P. Leff, and N. P. Shankley. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 47: 255-266 (1995).
25. Leff, P., I. G. Dougall, and D. Harper. Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model-fitting approach. Br. J. Pharmacol. 110:239-244 (1993).
26. Patel, Y. C., and C. B. Srikant. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135:2814-2817 (1994).
27. -) cells. Br. J. Pharmacol. 117:639-646 (1996).
28. Wieland, T., and K. H. Jakobs. Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. Methods Enzymol 237:3-13 (1994).
29. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47:848-854 (1995).
30. 2+ and the βγ-subunit complex on the interactions of guanine nucleotides with G proteins. J. Biol. Chem. 262:762-766 (1987).
31. Gilman, A. G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:615-649 (1987).
32. 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol. Pharmacol. 45:524-531 (1994).
33. ++ channel in the pituitary cell line AtT-20. Neuroscience 71: 1073-1081 (1996).
34. Costa, T., J. Lang, C. Gless, and A. Herz. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions. Mol. Pharmacol. 37:383-394 (1990).
35. Costa, T., Y. Ogino, P. J. Munson, H. O. Onaran, and D. Rodbard. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 41:549-560 (1992).
36. Kenakin, T. P., Ferris, R. M. Effects of in vivo β-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol. J. Cardiovasc. Pharmacol. 5:90-97 (1983).
37. Neve, K. A., B. A. Cox, R. A. Henningsen, A. Spanoyannis, and R. L. Neve. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol. 39:733-739 (1991).
38. 2-adrenergic receptors by sodium. J. Biol. Chem. 265:21590-21595 (1990).
39. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science (Washington D. C.) 257:977-980 (1992).
40. + regulation of agonist binding but does not alter receptor-G protein association. Mol. Pharmacol. 44:380-384 (1993).